BYOMass Company

BYOMass is developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses.


Investors

Headquarters: Sudbury, Massachusetts, United States
Employee Number: 1-10
Technology: Geroscience
Industry: Biotechnology
Total Funding: 1500000
Number Of Exists: Venture - Series Unknown
Investors Number: 1
Last Funding Date: 2019
Investor Type: Company
Founded Date: 2017
Last Funding Type: Venture - Series Unknown